De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Zecon Berhad Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Zecon Berhad heeft een totaal eigen vermogen van MYR415.6M en een totale schuld van MYR701.2M, wat de schuld-eigenvermogensverhouding op 168.7% brengt. De totale activa en totale passiva bedragen respectievelijk MYR1.6B en MYR1.2B. De EBIT Zecon Berhad is MYR56.8M waardoor de rentedekking 1.2 is. Het heeft contanten en kortetermijnbeleggingen van MYR36.6M.

Belangrijke informatie

168.7%

Verhouding schuld/eigen vermogen

RM 701.22m

Schuld

Rente dekkingsratio	1.2x
Contant	RM 36.64m
Aandelen	RM 415.63m
Totaal verplichtingen	RM 1.21b
Totaal activa	RM 1.62b

Recente financiële gezondheidsupdates

Recent updates

Zecon Berhad (KLSE:ZECON) Use Of Debt Could Be Considered Risky

Aug 06

Here's Why Zecon Berhad (KLSE:ZECON) Is Weighed Down By Its Debt Load

May 07

Zecon Berhad (KLSE:ZECON) Might Have The Makings Of A Multi-Bagger

Feb 13

Here's Why Zecon Berhad (KLSE:ZECON) Is Weighed Down By Its Debt Load

Oct 26

The Returns On Capital At Zecon Berhad (KLSE:ZECON) Don't Inspire Confidence

Jul 06

Is Zecon Berhad (KLSE:ZECON) Using Too Much Debt?

Dec 14

We Like These Underlying Trends At Zecon Berhad (KLSE:ZECON)

Mar 03

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( MYR202.4M ) van ZECON } dekken niet de korte termijn passiva ( MYR1.1B ).

Langlopende schulden: De kortetermijnactiva ZECON ( MYR202.4M ) overtreffen de langetermijnschulden ( MYR115.0M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 159.9% ) ZECON wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van ZECON is de afgelopen 5 jaar gedaald van 191.8% naar 168.7%.

Schuldendekking: De schuld van ZECON wordt niet goed gedekt door de operationele kasstroom ( 5.6% ).

Rentedekking: De rentebetalingen van ZECON op haar schulden worden niet goed gedekt door EBIT ( 1.2 x dekking).

Zecon Berhad Balans Gezondheid

Financiële gezondheid criteriumcontroles 2/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Zecon Berhad (KLSE:ZECON) Use Of Debt Could Be Considered Risky

Here's Why Zecon Berhad (KLSE:ZECON) Is Weighed Down By Its Debt Load

Here's Why Zecon Berhad (KLSE:ZECON) Is Weighed Down By Its Debt Load

Is Zecon Berhad (KLSE:ZECON) Using Too Much Debt?

Recent updates

Second quarter 2024 earnings released: RM0.003 loss per share (vs RM0.002 loss in 2Q 2023)

Zecon Berhad (KLSE:ZECON) Use Of Debt Could Be Considered Risky

Zecon Berhad Appoints datu Haji Hashim Bin Haji Bojet as Independent and Non Executive Director

New major risk - Revenue and earnings growth

First quarter 2024 earnings released: EPS: RM0.001 (vs RM0.009 in 1Q 2023)

Here's Why Zecon Berhad (KLSE:ZECON) Is Weighed Down By Its Debt Load

Zecon Berhad, Annual General Meeting, Jun 18, 2024

Full year 2023 earnings released: EPS: RM0.014 (vs RM0.029 loss in FY 2022)

Zecon Berhad (KLSE:ZECON) Might Have The Makings Of A Multi-Bagger

New minor risk - Share price stability

Third quarter 2023 earnings released: RM0.056 loss per share (vs RM0.006 profit in 3Q 2022)

Affin Hwang Investment Bank Berhad, Affin Bank Berhad and Bank Pembangunan Malaysia Berhad Provides Court Update Against Zecon Berhad

Here's Why Zecon Berhad (KLSE:ZECON) Is Weighed Down By Its Debt Load

Zecon Berhad Appoints ENCIK MOHAMMED NOOR BIN AHMAD as Independent and Non Executive Member of Audit Committee

Second quarter 2023 earnings released: RM0.002 loss per share (vs RM0.03 loss in 2Q 2022)

New minor risk - Share price stability

First quarter 2023 earnings released: EPS: RM0.009 (vs RM0.017 in 1Q 2022)

Zecon Berhad Announces Resignation of Encik Richard Kiew Jiat Fong as Independent and Non Executive Member of Nomination and Remuneration Committee

Zecon Berhad Appoints Datu Rodziah Binti Morshidi as Independent and Non Executive Director

Full year 2022 earnings released: RM0.028 loss per share (vs RM0.10 loss in FY 2021)

Insufficient new directors

Affin Hwang Investment Bank Berhad, Affin Bank Berhad and Bank Pembangunan Malaysia Berhad Provides Court Update Against Zecon Berhad

Third quarter 2022 earnings released: EPS: RM0.006 (vs RM0.11 loss in 3Q 2021)

Insufficient new directors

Affin Hwang Investment Bank Berhad, Affin Bank Berhad and Bank Pembangunan Malaysia Berhad Announces Announcement on the Status of Default in Payment

Second quarter 2022 earnings released: RM0.03 loss per share (vs RM0.011 profit in 2Q 2021)

The Returns On Capital At Zecon Berhad (KLSE:ZECON) Don't Inspire Confidence

Insufficient new directors

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Insufficient new directors

Now 23% undervalued after recent price drop

Now 21% undervalued after recent price drop

Zecon Berhad Appoints Mohammed Noor Bin Ahmad as Independent and Non-Executive Member of Risk Committee

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Is Zecon Berhad (KLSE:ZECON) Using Too Much Debt?

Insufficient new directors

Full year 2021 earnings released: RM0.026 loss per share (vs RM0.25 profit in FY 2020)

Zecon Berhad Announces Status of Lawsuit for Default in Payment

Third quarter 2021 earnings released: EPS RM0.015 (vs RM0.063 in 3Q 2020)

Zecon Berhad Announces Status of Lawsuit for Default in Payment

We Like These Underlying Trends At Zecon Berhad (KLSE:ZECON)

Second quarter 2021 earnings released: RM0.009 loss per share (vs RM0.035 profit in 2Q 2020)

First quarter 2021 earnings released: RM0.044 loss per share

New 90-day low: RM0.41

New 90-day low: RM0.41

New 90-day low: RM0.45

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven